Categories: Newsweek

11/29/2018

Newsweek trumpets an ‘aggressive’ new cancer drug, but where’s the data?

10/2/2018

Newsweek overlooks key limitation of study on vitamin D and childhood obesity

9/21/2018

Newsweek story on Zika vaccine to zap brain cancer is fascinating–but needed more caution about mouse research

8/23/2018

Newsweek’s premature optimism about experimental ovarian cancer drug overlooks costs, harms and limitations of the evidence

8/6/2018

Newsweek prematurely reports ‘promise’ for ketamine as a treatment for depressed teens

6/21/2018

Newsweek’s story on the 16:8 diet: It’s not much more than a news release rewrite, but it’s at least cautious

6/14/2018

Here’s one detail that should be included in almost all stories about cancer screening studies

5/11/2018

Newsweek stokes false hope with ‘cure for baldness’ based on preliminary evidence

3/22/2018

Like so many news stories before it, Newsweek article makes male birth control pill sound imminent

2/26/2018

Retinal scans to detect heart attack risk? Newsweek offers a blurry picture

Story Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

HealthNewsReview.org @HealthNewsRevu·

A week like this should teach you how/what to ignore: #COVID19 news & PR about studies in monkeys & mice...about studies of dishonesty & BMI…and about rating attractiveness of women with endometriosis!!! https://www.healthnewsreview.org/2020/08/crazy-week-of-pr-news-on-studies-should-teach-us-how-what-to-ignore/

Reply on Twitter 1291431630490480642 Retweet on Twitter 12914316304904806421 Like on Twitter 12914316304904806423 Twitter 1291431630490480642

Retweet on Twitter HealthNewsReview.org Retweeted

Elizabeth Kay Mendes @LizKayMendes·

“to project certainty where it simply does not exist is communication malpractice at a time like this and with a public health issue like this.” ⁦@garyschwitzer⁩ on ⁦@ContentScience⁩ https://review.content-science.com/covering-covid-19-vaccine-news-part-two-from-the-publisher-of-health-news-review/

Reply on Twitter 1291075113526464512 Retweet on Twitter 12910751135264645125 Like on Twitter 12910751135264645122 Twitter 1291075113526464512

Retweet on Twitter HealthNewsReview.org Retweeted

Elaine Schattner MD, MA @ESchattner·

In case you weren't aware: Prestigious journalism organizations and outlets take money from pharma, @garyschwitzer https://www.healthnewsreview.org/2020/08/drug-company-influence-on-journalism/#.XyrYGZeNvXA.twitter @HealthNewsRevu

Reply on Twitter 1291042197752745985 Retweet on Twitter 12910421977527459851 Like on Twitter 12910421977527459855 Twitter 1291042197752745985

Categories: Newsweek

Newsweek trumpets an ‘aggressive’ new cancer drug, but where’s the data?

Newsweek overlooks key limitation of study on vitamin D and childhood obesity

Newsweek story on Zika vaccine to zap brain cancer is fascinating–but needed more caution about mouse research

Newsweek’s premature optimism about experimental ovarian cancer drug overlooks costs, harms and limitations of the evidence

Newsweek prematurely reports ‘promise’ for ketamine as a treatment for depressed teens

Newsweek’s story on the 16:8 diet: It’s not much more than a news release rewrite, but it’s at least cautious

Here’s one detail that should be included in almost all stories about cancer screening studies

Newsweek stokes false hope with ‘cure for baldness’ based on preliminary evidence

Like so many news stories before it, Newsweek article makes male birth control pill sound imminent

Retinal scans to detect heart attack risk? Newsweek offers a blurry picture

Story Reviews

@HealthNewsRevu

Categories

Tags